Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine-tolerant rats
- PMID: 12151557
- PMCID: PMC6758136
- DOI: 10.1523/JNEUROSCI.22-15-06773.2002
Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine-tolerant rats
Abstract
We investigated the effect of chronic administration of morphine on noxious stimulus-induced antinociception (NSIA) produced by intraplantar capsaicin injection. In the untreated (naive) rat, we previously found that NSIA depends on activation of dopamine, nicotinic acetylcholine, and mu- and delta-opioid receptors in nucleus accumbens. Rats chronically implanted with subcutaneous morphine pellets demonstrated tolerance to the antinociceptive effects of acute systemic morphine administration but did not show cross-tolerance to NSIA. Morphine pretreatment, however, significantly reduced NSIA dependence on intra-accumbens opioid receptors but not on dopamine or nicotinic acetylcholine receptors. As observed in naive rats, intra-accumbens microinjection of either the dopamine receptor antagonist flupentixol or the nicotinic receptor antagonist mecamylamine blocked NSIA in rats tolerant to the antinociceptive effects of morphine, but, in contrast to naive rats, intra-accumbens microinjection of either the mu-receptor antagonist Cys2,Tyr3,Orn5,Pen7 amide or the delta-receptor antagonist naltrindole failed to block NSIA. These findings suggest that although NSIA is dependent on nucleus accumbens opioid receptors in the naive state, this dependence disappears in rats tolerant to the antinociceptive effects of morphine, which may account for the lack of NSIA cross-tolerance. In separate experiments, intra-accumbens extracellular dopamine levels were measured using microdialysis. Dopamine levels increased after either capsaicin or systemic morphine administration in naive rats but only after capsaicin administration in morphine pretreated rats. Thus, intra-accumbens dopamine release paralleled antinociceptive responses in naive and morphine pretreated rats.
Figures







Similar articles
-
Adaptations in nucleus accumbens circuitry during opioid withdrawal associated with persistence of noxious stimulus-induced antinociception in the rat.J Pain. 2003 Apr;4(3):141-7. doi: 10.1054/jpai.2003.12. J Pain. 2003. PMID: 14622711
-
Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens.Neuroscience. 2001;106(1):129-36. doi: 10.1016/s0306-4522(01)00264-0. Neuroscience. 2001. PMID: 11564423
-
mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.Eur J Neurosci. 2002 Mar;15(5):861-8. doi: 10.1046/j.1460-9568.2002.01915.x. Eur J Neurosci. 2002. PMID: 11906528
-
Contribution of spinal inhibitory receptors in heterosegmental antinociception induced by noxious stimulation.Eur J Neurosci. 2003 Dec;18(11):2999-3006. doi: 10.1111/j.1460-9568.2003.03031.x. Eur J Neurosci. 2003. PMID: 14656295
-
Mechanisms underlying δ- and μ-opioid receptor agonist-induced increases in extracellular dopamine level in the nucleus accumbens of freely moving rats.J Oral Sci. 2017;59(2):195-200. doi: 10.2334/josnusd.16-0874. J Oral Sci. 2017. PMID: 28637978 Review.
Cited by
-
Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia.Front Immunol. 2022 Aug 10;13:929222. doi: 10.3389/fimmu.2022.929222. eCollection 2022. Front Immunol. 2022. PMID: 36032146 Free PMC article.
-
Upregulation of nerve growth factor in central amygdala increases sensitivity to opioid reward.Neuropsychopharmacology. 2012 Dec;37(13):2780-8. doi: 10.1038/npp.2012.144. Epub 2012 Aug 8. Neuropsychopharmacology. 2012. PMID: 22871918 Free PMC article.
-
Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry.Clin Transl Sci. 2013 Oct;6(5):400-3. doi: 10.1111/cts.12075. Epub 2013 Jun 13. Clin Transl Sci. 2013. PMID: 24127930 Free PMC article. Clinical Trial.
-
Rostral ventral medulla cholinergic mechanism in pain-induced analgesia.Neurosci Lett. 2009 Oct 30;464(3):170-2. doi: 10.1016/j.neulet.2009.08.036. Epub 2009 Aug 20. Neurosci Lett. 2009. PMID: 19699268 Free PMC article.
-
Simultaneous fMRI-PET of the opioidergic pain system in human brain.Neuroimage. 2014 Nov 15;102 Pt 2(0 2):275-82. doi: 10.1016/j.neuroimage.2014.07.058. Epub 2014 Aug 6. Neuroimage. 2014. PMID: 25107855 Free PMC article.
References
-
- Ableitner A, Schulz R. Neuroanatomical sites mediating the central actions of beta-endorphin as mapped by changes in glucose utilization: involvement of mu opioid receptors. J Pharmacol Exp Ther. 1992;262:415–423. - PubMed
-
- Ahn DK, Kim YS, Park JS. Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats. Neurosci Lett. 1998;243:105–108. - PubMed
-
- Altier N, Stewart J. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J Pharmacol Exp Ther. 1998;285:208–215. - PubMed
-
- Altier N, Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 1999;65:2269–2287. - PubMed
-
- Badiani A, Leone P, Stewart J. Intra-VTA injections of the mu-opioid antagonist CTOP enhance locomotor activity. Brain Res. 1995;690:112–116. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials